TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma
Latest Information Update: 08 Sep 2023
At a glance
- Drugs Lenvatinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Sep 2021 Status changed from not yet recruiting to recruiting.
- 03 Aug 2020 New trial record